Artrya Limited (ASX:AYA)
Australia · Delayed Price · Currency is AUD 4.010
-0.070 (-1.72%)
Apr 28, 2026, 4:10 PM AEST
Artrya Revenue
Artrya had revenue of 14.00K AUD in the half year ending December 31, 2025. This brings the company's revenue in the last twelve months to 29.00K, up 123.08% year-over-year. In the fiscal year ending June 30, 2025, Artrya had annual revenue of 28.00K.
Revenue (ttm)
29.00K
Revenue Growth
+123.08%
P/S Ratio
22,482.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
651.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 28.00K | - | - |
| Jun 30, 2024 | - | - | - |
| Jun 30, 2023 | - | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | - | - | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cogstate | 84.06M |
| Doctor Care Anywhere Group | 76.65M |
| Alcidion Group | 48.62M |
| Mach7 Technologies | 29.70M |
| Oneview Healthcare | 21.12M |
| PharmX Technologies | 7.65M |
| Vitasora Health | 5.01M |
| Emyria | 2.29M |
Artrya News
- 3 months ago - Artrya Earnings Call Transcript: Q2 2026 - Transcripts
- 5 months ago - Artrya Transcript: Bell Potter Healthcare Conference 2025 - Transcripts
- 5 months ago - Artrya Transcript: AGM 2025 - Transcripts
- 6 months ago - Artrya Earnings Call Transcript: Q1 2026 - Transcripts
- 8 months ago - Artrya Transcript: FDA Announcement - Transcripts
- 9 months ago - Artrya Earnings Call Transcript: Q4 2025 - Transcripts
- 1 year ago - Artrya Earnings Call Transcript: Q3 2025 - Transcripts
- 1 year ago - Artrya Transcript: FDA Announcement - Transcripts